Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
1 clinical trials · Condition
◉ Watch Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL) (NCT00154102) | Merck KGaA, Darmstadt, Germany | 2004-05-01 |
Track Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.